D. Dombagoda

A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

D. Montefiori, N. Letvin, D. Venzon, 2007, Journal of Virology.

A mouse monoclonal antibody against Epstein-Barr virus envelope glycoprotein 350 prevents infection both in vitro and in vivo.

G. Mieli-Vergani, G. Hale, D. Crawford, 2006, The Journal of infectious diseases.

Vaccination with DC/tumor fusion cells results in cellular and humoral anti-tumor immune responses in patients with multiple myeloma DC/myeloma fusion vaccine induces immune responses

N. Munshi, P. Richardson, D. Kufe, 2017 .

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

A. Swerdlow, D. Crawford, Clare Taylor, 2002, The Lancet.

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.

N. Munshi, P. Richardson, D. Kufe, 2011, Blood.

No Evidence for Consistent Virus-Specific Immunity in Simian Immunodeficiency Virus-Exposed, Uninfected Rhesus Monkeys

Gary J. Nabel, Norman L. Letvin, John R. Mascola, 2007, Journal of Virology.